










































Expansion of human midbrain floor plate progenitors from
induced pluripotent stem cells increases dopaminergic neuron
differentiation potential
Citation for published version:
Fedele, S, Collo, G, Behr, K, Bischofberger, J, Muller, S, Kunath, T, Christensen, K, Gunder, AL, Graf, M,
Jagasia, R & Taylor, V 2017, 'Expansion of human midbrain floor plate progenitors from induced pluripotent
stem cells increases dopaminergic neuron differentiation potential' Scientific Reports, vol. 7, no. 1. DOI:
10.1038/s41598-017-05633-1
Digital Object Identifier (DOI):
10.1038/s41598-017-05633-1
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons license and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from
the
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2017
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 09. May. 2019
1SciEntific REpoRts | 7: 6036  | DOI:10.1038/s41598-017-05633-1
www.nature.com/scientificreports
Expansion of human midbrain 
floor plate progenitors from 
induced pluripotent stem cells 
increases dopaminergic neuron 
differentiation potential
Stefania Fedele1, Ginetta Collo1,2, Katharina Behr3, Josef Bischofberger3, Stephan Müller4, 
Tilo Kunath  5, Klaus Christensen4, Anna Lisa Gündner4, Martin Graf4, Ravi Jagasia4 &  
Verdon Taylor1
Human induced pluripotent stem cells (hiPSCs) are invaluable to study developmental processes and 
disease mechanisms particularly in the brain. hiPSCs can be differentiated into mature and functional 
dopaminergic (DA) neurons. Having robust protocols for the generation of differentiated DA neurons 
from pluripotent cells is a prerequisite for the use of hiPSCs to study disease mechanisms, for drug 
discovery, and eventually for cell replacement therapy. Here, we describe a protocol for generating 
and expanding large numbers of homogeneous midbrain floor plate progenitors (mFPPs) that retain 
efficient DA neurogenic potential over multiple passages and can be cryobanked. We demonstrate that 
expanded mFPPs have increased DA neuron potential and differentiate more efficiently and rapidly 
than progenitors generated by standard protocols. In addition, this novel method results in increased 
numbers of DA neurons that in vitro show characteristic electrophysiological properties of nigrostriatal 
DA neurons, produce high levels of dopamine, and integrate into host mice when grafted in vivo. Thus, 
we describe a robust method for producing human mesencephalic DA neurons from hiPSCs.
Human pluripotent stem cells, including embryonic stem cells and hiPSCs, can be expanded in vitro and retain 
their capacity to differentiate into any cell type of the three germ layers1, 2. Hypothetically, they represent an 
unlimited source of cells for several applications including drug screening and cell replacement therapy for treat-
ment of neurological disorders. Parkinson´s disease (PD), the second most common neurodegenerative disorder, 
is characterized by the selective loss of DA neurons of the substantia nigra of the midbrain3, 4. Although recent 
advances have been made in our understanding of the pathogenesis of PD, at present there are no cures and 
the main treatment for patients are DA analogues and receptor agonists to counteract the reductions in DA5–7. 
Numerous protocols have been developed to generate human DA neurons in vitro from pluripotent cells8–14. 
These methods rely on the directed differentiation of pluripotent cells using small molecules and growth factors 
either through an embryoid body or neurosphere step or in adherent culture8–18. These procedures are often labo-
rious, long and highly variable resulting in heterogeneous differentiation with relatively low numbers of midbrain 
DA neurons. In order to use hiPSC-derived DA neurons for addressing gene function, for drug screening or 
eventual cell replacement therapy, a homogeneous, robust and rapid method would be a significant advantage19. 
Here we describe a robust and reproducible method that takes advantage of the mFPP-based differentiation strat-
egy to generate cultures of ~100% LMX1A+FOXA2+ mFPP cells that can be expanded and maintained as a 
pure population11. This method takes advantage of the molecular pathways that guide DA neuron formation in 
1Department of Biomedicine, University of Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland. 2Department of 
Molecular and Translational Medicine, Viale Europa 11, 25123, Brescia, Italy. 3Department of Biomedicine, University 
of Basel, Pestalozzistrasse 20, CH-4056, Basel, Switzerland. 4Pharma Research & Early Development, Roche 
Innovation Center Basel, F. Hoffmann-La Roche, Grenzacherstrasse 124, CH-4070, Basel, Switzerland. 5MRC Centre 
for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, EH93JQ, Edinburgh, United Kingdom. 
Correspondence and requests for materials should be addressed to V.T. (email: verdon.taylor@unibas.ch)
Received: 6 April 2017
Accepted: 31 May 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SciEntific REpoRts | 7: 6036  | DOI:10.1038/s41598-017-05633-1
vivo and can be used to generate a large number of mFPPs that can be passaged more than 6 times in vitro while 
retaining DA neuron differentiation potential. We also show that expanded mFPPs can be frozen and thawed and 
that they generate mature DA neurons in vitro with higher efficiency than those generated by standard protocols. 
Therefore, this protocol allows for expansion and banking of expanded mFPP for large-scale generation of mature 
and functional DA neurons in vitro and in vivo and circumvents some of the variability often seen with protocols 
that require differentiation from pluripotent cells without the possibility of progenitor expansion. The generation 
of expandable mFPPs on a large scale also makes this protocol advantageous for understanding cellular and 
molecular mechanisms of early human DA neuron development, generating large numbers of mFPPs or DA 
neurons for drug screening, and transplantation.
Results
Human iPSC-derived mFPPs can be expanded in vitro. Many DA neuron differentiation methods 
have been developed using human pluripotent stem cells as a cell of origin. Some protocols require the differenti-
ation of cells via a embryoid body, 3D culture or neurosphere step14, 20 or induction of a pan-neural progenitor cell 
state21–23 for the formation of primitive neuroepithelia and neuronal rosette-like structures followed by ventral-
ization to a mesencephalic fate. However, a mixture of dorsal and ventral neural subtypes are usually generated 
in these cultures including DA neurons, motor neurons, astrocytes and oligodendrocytes21, 24, 25. mFPP-based 
differentiation strategies were described in which sequentially factor application to the iPSCs results in directed 
ventralization and the generation of mFPPs10, 11, 26–28. The mFPPs are committed precursors which generate mes-
encephalic DA neurons in vivo. None of these methods take advantage of a DA neuron-specified progenitor cell 
population.
We developed a robust method for long-term expansion of a pure population of hiPSCs-derived mFPPs main-
tained in feeder-free and adherent conditions to be used as a potential source of enriched DA neuron cultures. 
To circumvent the heterogeneity often associated with embryoid body and neurosphere-based differentiation 
protocols we took advantage of the accessibility of 2D cultures to manipulate signaling pathways and bioac-
tive molecules and factors in chemically defined serum-free media. hiPSCs were cultured on Matrigel under 
defined conditions in mTeSR-1 medium (see Methods). Subconfluent hiPSCs were passaged onto fresh Matrigel 
coated plates and cultured for 24 hours in iPSC medium to 90–100% confluency. Once confluent, the medium 
was changed to floor plate induction medium (n.1) and cultured for 2 days, replacing the medium every day 
(Fig. 1a,b). At day 3 after starting the floor plate induction with FGF8, SHH, and Purmorphamin, WNT signa-
ling was activated by addition of the GSK3-β inhibitor CHIR-99021 to the n.1 medium. On day 5, the medium 
was gradually switched to floor plate expansion medium (n.2) and SB-431542 was omitted from the culture 
(Fig. 1a,b). By day 11 the cells were growing in an n.1/n.2 medium ratio of 1:3. At this point, cells were passaged 
and replated onto fresh Matrigel coated plates in n.2 medium at a density of 75 × 103 cells/cm2. Cells were main-
tained in n.2 medium until 90–95% confluency (4–5 days) exchanging the medium every 2nd day (Fig. 1a,b). Once 
the mFPPs had reached 90–95% confluency, they were passaged and replated onto fresh Matrigel coated plates at 
a density of 75 × 103 cells/cm2 and cultured further in n.2 medium. We passaged and replated the mFPPs every 
4–5 days for at least 6 passages and cells were cryobanked at each passage (see Methods).
At day 11 of floor plate induction, 90–95% of the cells expressed the mFPPs markers LMX1A and FOXA2 
and very few PAX6+ dorsal progenitor cells were present in the cultures, demonstrating the efficient and homo-
geneous mFPP induction11 (Fig. S1a). We examined whether the expanded mFFPs retained their characteristics 
with extended culture. The cells retained their morphology, forming a compact monolayer of cells that gradually 
became confluent (Fig. 2a). They also remained homogeneous in expression of the LMX1A and FOXA2 while 
PAX6+ cells were not detected (Figs 2b and S1b).
On average, 1.25 × 106 ± 0.38 × 106 mFPPs were generated at day 11 of the floor plate induction culture from 
5 × 105 hiPSCs. The mFPPs were dissociated and replated for >6 passages (4 weeks on average). Upon reaching 
confluency at the end of passage 6, 8.9 × 108 ± 1 × 108 hiPSC-derived mFPPs had been generated from the initial 
5 × 105 hiPSCs (Fig. 2c). Hence, we achieved a 720-fold increase in the number of mFPPs compared to the num-
ber at day 11 and a 1780-fold increase over the initial number of hiPSCs plated.
Expanded mFPPs give rise to higher numbers of DA neurons at the early stage of differentia-
tion. We examined whether expanded mFPPs maintain their DA neuron differentiation potential compared to 
progenitors generated using a standard differentiation procedure. DA neuron differentiation was induced when 
the expanded mFPPs reached 90–100% confluency by switching the cultures to differentiation medium contain-
ing BDNF, GDNF, ascorbic acid, cAMP, β-TGF3 and DAPT (Fig. 1 and see Methods). After one week of induc-
tion (early phase of DA neuron differentiation), the expanded mFPPs cultures produced Tyrosine Hydroxylase 
positive (TH+) and βIII-Tubulin positive (βIII-Tub+) neurons (Fig. 3a). Quantification of differentiation by flu-
orescent assisted cell sorting (FACS) or microscopic analysis showed that although the proportion of βIII-Tub+ 
neurons was comparable to the standard procedure, the number of TH+ neurons was increased 6.8–7.4-fold 
(Fig. 3a–c). Hence, mFPP expansion did not interfere with general neuronal fate induction, resulting in an 
increase in TH+ neurons by day 20 (Figs 3 and S2).
mFPP expansion increases the potential to generate mature and functional DA neurons in the 
late stage of differentiation. We passaged the induced and differentiating mFPP cells on day 20, after 
expansion on Matrigel coated dishes, to Laminin/Fibronectin-coated plates (standard method: day 20; expansion 
method: day 20+exp) (Fig. 1). The cells from the expanded mFPP cultures and the standard cultures plated equally 
well. Morphologically, the mFPP cells already took on a more differentiated phenotype after one day (day 21) 
on Laminin/Fibronectin compared to cells cultured under standard conditions, the latter mostly had a flattened 
progenitor-like morphology (Figs 4 and S3). Three days after plating onto Laminin/Fibronectin-coated plates 
www.nature.com/scientificreports/
3SciEntific REpoRts | 7: 6036  | DOI:10.1038/s41598-017-05633-1
and induction of differentiation, the expanded mFPPs had generated neuron-like cells that extended processes 
throughout the culture dish (Figs 4 and S3). Many of the expanded mFPP progenitors condensed to form brain 
nucleus-like structures from which cells and processes radiated. This nucleation of the cells was less evident in the 
standard cultures of the same age (Figs 4 and S3). The condensation of the cells and the enhanced morphological 
changes were conserved over 6 passages (Fig. S3b). The differentiating neurons were maintained differentiation 
medium for up to 80 days in order to complete DA neuron maturation (late phase of DA neuron differentiation) 
(Fig. 1).
We analyzed the expression of DA neuron markers by immunostaining and RT-PCR during the course of the 
maturation procedure and compared the standard culture-derived and expanded mFPP-derived cells (Fig. 5a,b). 
From day 30 of maturation, some FOXA2+ cells expressed the DA neuron marker TH (Fig. 5a). In addition, 
TH+ DA neurons also expressed the transcription factor NURR1 (Fig. 5a). At late stages of the differentiation 
Figure 1. Schematic diagram for efficient expansion of in vitro DA neuron progenitors and final DA neuron 
maturation from human iPSCs. (a) In vitro DA neurons were generated using a standard mFFP protocol11 with 
some modifications. After 11 days of neuralisation and floor plate induction by adding signaling molecules 
such as SHH, FGF8 and CHIR-99021, mFPPs were amplified by cell passaging and maintained in culture for 
3–4 weeks (6 passages in total as indicated by the arrows P1–P6). During progenitor expansion, cells were 
maintained into LDN-193189 and CHIR-99021. After cell expansion, differentiation of mFPPs into mature and 
functional DA neurons was induced up to day 50–80 (from day 12+EXP to day 50–80+EXP). (b) Flow diagram 
of mFPP expansion and DA neuron differentiation with description of the most important steps and possible 
applications. FP-1, floor plate induction medium n.1; FP-2, floor plate expansion medium n.2; DA diff, DA 
differentiation medium; LDN, LDN-193189; SB, SB431542; Purm, Purmorphamine; CHIR, CHIR-99021; 
BACGTD, BDNF, ascorbic acid, cAMP, GDNF, TGF-β3, DAPT.
www.nature.com/scientificreports/
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procedure, the TH+ DA neurons expressed markers of terminal differentiation including the vesicular monoam-
ine transporter VMAT2 and G protein-activated inward rectifier potassium channel GIRK2 (Fig. 5a). Expression 
of additional markers of DA neuron differentiation including the Dopamine active transporter 1 DAT and 
the transcription factor Pituitary homeobox 3 PITX3 was detectable in the mFPP-derived neuron cultures by 
Figure 2. Characterization of hiPSC-derived expanded mFPPs. (a) Typical morphology of hiPSC-derived 
expanded mFPPs at passage 4 (P4) one and four days after passaging. Progenitors proliferated and reached 
100% confluency within 3–4 days at each passage. (b) Immunocytochemical analysis of expanded mFPPs at 
passage 4 (P4) showed the expression for LMX1A, FOXA2 and NESTIN. No PAX6+ cells were observed during 
the expansion, demonstrating the maintenance of midbrain floor plate phenotype. (c) Representation of total 
number of mFPPs generated after 6 passages (P1–P6) in three independent experiments. At the end of the 
expansion (P6), 8.9 × 108 ± 1 × 108 progenitors were produced in total. Scale bars: 200 μm and 100 μm in a and 
50 μm in b.
www.nature.com/scientificreports/
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Figure 3. hiPSC-derived expanded mFPPs give rise to higher numbers of TH+ neurons at an early stage of DA 
neuron differentiation. (a) Immunocytochemical analysis of DA neurons generated by using the expansion 
method showed higher proportion of TH+ neurons compared to the standard protocol. Cells were stained with 
antibodies against TH and βIII-Tub (Table S1). (b) Dot plots of single-cell suspensions of one representative 
differentiation experiment using the expansion method showed higher percentages of TH+βIII-Tub+ neurons 
generated at day 20 compared to the standard protocol (8.70% vs 1.18%). Negative control sample was used 
to determine the gating parameters for cell quantification. (c) Comparative analysis of total positive neurons 
for βIII-Tub and TH markers generated at day 20 by using the standard method and the expansion protocol. 
Similar percentages of βIII-Tub+ neurons were measured using both protocols, suggesting that the progenitor 
expansion did not interfere with neuronal induction fate. Higher proportion of TH+ cells were obtained after 
progenitor expansion (8.06 ± 2.45%) in comparison to the standard method (1.18 ± 0.14%), resulting in a 6.83-
fold increase of TH+ cells. Student’s t-test. Mean ± S.E.M. (n = 3–5). Scale bar: 50 μm.
Figure 4. Typical cell morphology in DA neuron cell cultures obtained by using the standard and the expansion 
methods. (a) Phase image of cells after 21 (D21) and 23 days (D23) of differentiation using the standard 
protocol. (b) Phase image of cells after 21+EXP (D21+EXP) and 23+EXP (D23+EXP) days of differentiation using the 
expansion protocol. Using the expansion method, higher numbers of cells with typical neuronal morphology 
were generated. At D23+EXP, a thick net of cells with long processes could be observed, suggesting the higher 
efficiency of expanded progenitor-derived DA neuronal differentiation compared to the standard method. Scale 
bars: 100 μm.
www.nature.com/scientificreports/
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Figure 5. hiPSC-derived expanded mFPPs maintain their capability to differentiate into mature and functional 
DA neurons in vitro. (a) Immunocytochemical analysis of expanded progenitor-derived DA neurons showed 
the expression of mature DA neuron specific markers, such as FOXA2, NURR1, VMAT2 and GIRK2. (b) 
RT-PCR analysis revealed the expression of mature DA neuron-specific markers, such as TH, VMAT2, 
GIRK2, PITX3 and DAT, in DA neuron cultures after different passages of expanded progenitors (P3–P6). 
The image contains cropped gel images showing the respective amplicons. Images of the full gels are shown in 
supplemental data Figure S4 (c) Quantitative gene expression analysis of mature DA neuron-specific markers, 
TH, VMAT2, GIRK2, PITX3 and DAT, showed no different between the standard and expansion protocols. 
However, DAT mRNA levels were found upregulated after progenitor expansion, suggesting a higher level of 
maturation in expanded progenitor-derived DA neuron cultures compared to the standard procedure. ANOVA 
test. Mean ± S.E.M. (n = 3). (d) Dopamine measurement by liquid chromatography-mass spectrometry (LC-
MS) in medium collected over time from DA neuron cultures generated by using either the standard or the 
expansion protocol. The analysis showed higher dopamine concentrations in expanded progenitor-derived 
DA neuron cultures compared to the standard cultures. Student’s t-test. Mean ± S.E.M. (n = 3–5). (e) Example 
of dopamine levels measured in cell cultures derived from the standard (28 ± 20 nM) and the expansion 
methods (180.59 ± 34.94 nM) at day 60 and day 60+EXP, respectively. Student’s t-test. Mean ± S.E.M. (n = 3–7). 
(f) Representative current-clamp example traces of an HCN-positive cell showing voltage sag response to 
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RT-PCR (Figs 5b and S4). Quantitative RT-PCR revealed that the expression of mature DA neuronal markers 
by neurons generated from expanded mFPPs was comparable to that of DA neurons generated by the standard 
procedure (Fig. 5c). However, expression of DAT was higher by DA neurons derived from expanded mFPPs than 
those derived by the standard method (Fig. 5c). In addition, with increasing passage number the mFPPs-derived 
neurons expressed higher levels of DAT suggesting that they either differentiate further or quicker than neurons 
generated by the standard procedure. These data suggest that expansion of mFPPs has a positive effect on the 
differentiation and maturation of DA neurons.
An important measure of DA neuron maturation and function is their functional release of dopamine29. We 
measured the levels of dopamine in the medium of DA neurons generated either by expanded mFPPs or via 
the standard protocol at the same day of differentiation. Liquid chromotography-mass spectrometric (LC-MS) 
analysis revealed consistently higher dopamine concentrations in the medium of expanded mFPP-derived DA 
neurons. This increase in dopamine levels in the medium of expanded mFPP-derived neurons started at day 40 
of differentiation and became most prominent at day 60 (180.6 ± 13.2 nM versus 28.0 ± 11.5 nM) (Fig. 5d,e). The 
6.5-fold increase in dopamine release by expanded mFPP-derived DA neurons supports an increased activity and 
quicker maturation.
To further assess functional maturation of DA neurons, we performed electrophysiological recordings at day 
50 of differentiation (Fig. 5f–i). Individual neurons were recorded in whole-cell voltage-clamp and current-clamp 
configuration in order to detect hyperpolarization-activated cyclic-nucleotide-gated channel (HCN) activity, 
which is a typical characteristic of mature mesencephalic DA neurons. For voltage-clamp recordings the resting 
membrane potential was set to −60 mV. Simultaneously, the patched neurons were filled with biocytin for sub-
sequent morphological analysis and TH immunostaining. 31.3% of the patched neurons (5 out of 16) displayed 
HCN-mediated currents (Fig. 5g), important for the typical voltage sag response of DA neurons upon hyper-
polarizing current injections (Fig. 5f). In those cells, the HCN-current amplitude (at −120 mV) was on average 
159 ± 41.2 pA (n = 5) compared to 0.39 ± 1.10 pA measured in non-HCN neurons (n = 11) (Figs 5h and S4). 
HCN-current positive neurons also showed a lower input resistance (average 0.26 ± 0.06 GΩ; n = 5) compared 
to HCN-negative neurons (average 2.81 ± 0.55 GΩ; n = 11) (Fig. 5i). All neurons with HCN current and sag 
response showed TH immunoreactivity confirming their DA neuron identity (Fig. 5j). These data indicate that 
DA neurons generated from expanded mFPPs reached a relatively advanced level of maturity in vitro and showed 
typical expression and electrophysiological characteristics of mesencephalic DA neurons comparable to neurons 
isolated from the brains of mice.
Expanded mFPPs give rise to DA neurons in vivo. We examined whether expanded mFPPs retain DA 
neuron differentiation potential in vivo by grafting cells at the progenitor stage and before differentiation into 
the ventral mesencephalon of recipient mouse embryos in utero using real-time ultrasound guided microcopy 
(Fig. 6a). The grafted human cells were detected in the mouse brain by their expression of the human nuclear 
antigen (HNA) or STEM121 to detect their cellular processes (Fig. 6b–d). Upon grafting into the mesencephalon 
of mouse embryos at embryonic day 11.5 (E11.5), and analysis at E18.5, expanded human mFPPs that had been 
passaged multiple times survived, integrated into the host and generated TH+ DA neurons in the graft area and 
in the region of the substantia nigra, adjacent to the endogenous DA neurons of the host (Fig. 6b). Graft-derived 
cells and processes were not detected in the striatum of host mice at this stage (data not shown). By postnatal 
day 10 (P10), human DA TH+STEM121+ neurons were still present at the original site of the graft and some 
TH+STEM121+ neurons were found integrated into the substantia nigra of the host (Fig. 6c). Moreover, grafted 
TH+STEM121+ human neurons in the brains of P10 hosts showed neuronal processes projecting to the striatum 
and arborizations within the striatum (Fig. 6d). We never observed overgrowth of the grafted cells nor tumor 
formation suggesting the expanded mFPPs have an additional advantage over the risk of grafting undifferentiated 
hiPSCs which could form teratomas.
Discussion
Here we describe and validate an important adaptation of the mFPP differentiation protocol for generating mes-
encephalic DA neurons. This protocol presents a number of advantages over previous protocols for generating 
and studying human DA neurons in culture. The mFPP protocol described previously takes advantage of the 
signaling networks which control midbrain formation and DA neuron differentiation10, 11, 27, 30, 31. Both genetic 
data in the mouse and in vitro differentiation experiments indicate that WNT signaling is important in roof 
plate function and mesencephalic DA neuron production in vivo32, 33. Although mesencephalic DA neurons are 
generated from a ventral progenitor pool and roof plate cells are the most dorsal cells in the neural tube, both DA 
neurons and roof plate share expression of LMX1A34–36. In addition, WNT signaling has been shown to activate 
LMX1A expression by neural progenitors37. During brain development, Wnt1 is expressed by neural progen-
itors at the mid-hindbrain boundary (Isthmus) and expression extends anteriorly along the dorsal midline38. 
hyperpolarizing current injections and marked action potentials after-hyperpolarization characteristic for DA 
neurons. (g) Representative voltage-clamp traces showing HCN currents in response to negative voltage steps. 
(h) Quantification of HCN current amplitude in HCN cells and non-HCN cells. HCN cells showed an average 
peak amplitude of 159 ± 41.2 pA (n = 5) versus 0.39 ± 1.10 pA measured in non-HCN cells (n = 11). Student’s 
t-test. Mean ± S.D. (i) Quantification of input resistance in HCN cells and non-HCN cells. HCN cells showed 
an average of 0.26 ± 0.06 GΩ (n = 5) versus 2.81 ± 0.55 GΩ detected in non-HCN cells (n = 11). Student’s 
t-test. Mean ± S.D. (j) Example of biocytin-filled HCN-positive cell, which was stained for TH expression. 
Immunofluorescent staining confirmed that HCN cells were effectively DA TH+ neurons. Scale bar: 20 μm.
www.nature.com/scientificreports/
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Wnt1 is an integral component of the Isthmus, controlling posterior midbrain and anterior hindbrain identity 
and development. DA neurons are born from mFPPs just anterior to the Isthmus39. The mFPP protocol also 
includes FGF8 in the initial induction steps. FGF8 is also a critical component of the Isthmus and an initiator 
Figure 6. hiPSC-derived expanded mFPPs maintain their capability to differentiate into mature DA neurons 
in vivo. (a) Schematic representation of transplantation experiments. After mFPP expansion, cells were grafted 
into the mesencephalon of mouse embryos at E11.5 and their DA neuron differentiation efficiency was analyzed 
in embryos (E18.5) and postnatal mice (P10). (b) Analysis of grafted human cells in E18.5 mouse brains showed 
the appearance of TH+ cells that migrated out from the transplantation area versus the substantia nigra of the 
host. (c) Immunofluorescent analysis for TH and STEM121 markers in postnatal P10 mouse brains showed the 
presence of high number of human TH+STEM121+ cells in the transplantation area and their integration in the 
substantia nigra of the host. (d) Analysis of grafted human cells in P10 mouse brains revealed the presence of 
TH+STEM121+ neuronal processes projected to the striatum and in the striatum. Scale bars: 500 μm in b, 50 μm 
in c and d.
www.nature.com/scientificreports/
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of the organizer identity40, 41. SHH is well known for its ventralizing activity during development of the central 
nervous system42–44. SHH is initially expressed from the axial mesoderm and induces its own expression in floor 
plate cells. Hence, SHH contributes to the ventral mesencephalic fate of the neural progenitors. In addition, 
activation of the SHH pathway in combination with WNT promotes FOXA2/LMX1A double positive mFFPs 
with prominent DA neuron potential37. mFPP-derived DA neurons have been shown previously to be func-
tional, and can rescue rodent and primate models of DA neuron degeneration upon grafting10, 11. However, one 
of the main challenges of the mFPP differentiation procedure has been to scale-up the production of neurons and 
establish reproducibility between human pluripotent cell lines. The direct differentiation of DA neurons from 
mFPPs is highly dependent upon the characteristics of the pluripotent cells and the efficiency of the initial floor 
plate determination step. Hence, we developed the culture conditions further to interrupt differentiation at the 
mFPP step and to expand these cells as a homogeneous population. The mFPPs continued to proliferate showing 
little spontaneously differentiation thus allowing for an increased period of expansion. We found that removing 
the activin-like receptor 5, 4 and 7 inhibitor SB-431542 and culturing the cells in n.2 medium in the presence 
of CHIR-99021 enhanced the expansion the maintenance of mFPPs. In contrast, presence of the activin-like 
receptor 2 and 3 inhibitor LDN-193189 was important for maintaining mFPPs. Addition of SHH and FGF8 did 
not increase mFPP expansion in n.2 medium (not shown). Previous studies have shown that the BMP4 inhibitor 
LDN-193189 is necessary to maintain/restrict human iPSCs to the neuroectodermal fate. On the other hand, the 
GSK3-β inhibitor CHIR99021 enhances survival of the FPPs at low cell density similar to its effects on embryonic 
stem cells to block differentiation and maintain self-renewal45. In addition, the Rock inhibitor Y-27632 was added 
to the expansion medium and promoted proliferation and maintained the morphology of FPPs in combination 
with CHIR99021. Y-27632 has been shown previously to enhance the survival and proliferation of dissociated 
human neural progenitor cells46, 47.
Interestingly, during extended expansion of the mFPPs, cytoplasmic expression of FOXA2 became apparent 
in addition to the nuclear localization. These findings support previous results indicating that Foxa2 is rapidly 
inactivated in vivo in mouse midbrain progenitors, and is necessary but not sufficient for specification of DA 
neurons in human pluripotent cells48, 49. Hence, we think that the increase in cytoplasmic expression and reduc-
tion of FOXA2 staining in the nucleus of mFPPs does not affect the DA neuron fate commitment and differen-
tiation efficiency in vitro. It is likely that as in the mouse in vivo, FOXA2 in DA progenitors is critical for fate 
specification rather than DA neuron maintenance. Moreover, we propose that FOXA2 alone is not essential to 
enrich for DA neurons, but other proteins such as LMX1A are likely more critical for DA neuron enrichment and 
differentiation.
This expansion procedure presents a number of advantages over the protocol for direct and continuous dif-
ferentiation from pluripotent cells. (1) Expanding mFPPs can be passaged several times and they retain their 
identity thereby enabling further amplification and increasing the number of DA neurons that can be generated. 
(2) Expanded mFPPs can be cryopreserved at each passage to generate a biobank of homogenous cells that can be 
thawed as a starting material for continued differentiation. (3) Finally, the mFPP expansion procedure is robust 
as similar results were obtained with three independent iPSC lines, NAS2 (all of the data shown here), Invitrogen 
iPSC (Episomal Human iPSC Line, Life Technologies, Cat. no. A13777) and a control line F3 (Collo et al. in 
preparation) (data not shown).
In previous descriptions of DA neuron differentiation using the mFPP protocol, the number of neurons gen-
erated seemed higher than in our experiments11, 27, 28. These differences between the studies could be due to dif-
ferences in the quantification methods or differences in the differentiation potential of the pluripotent cells used. 
Therefore, we made direct comparisons of the standard and mFPP expansion methods using the same iPSCs 
(NAS2) and quantification procedures (microscopy and FACS). To this end, we performed direct back-to-back 
comparisons with sister cultures differentiated via the standard direct mFPP protocol11. We felt it was important 
to test and compare the DA neurons generated from expanded mFPPs with those produced by the standard pro-
tocol not only at the transcriptome and protein level but also at the functional level. We found that the expansion 
period had significant beneficial effects on the degree and rate of differentiation of DA neurons in the cultures. 
Not only did the proportion of DA neurons increase approximately 7-fold, but the neurons also showed increased 
functional maturity as assessed by electrophysiology and release of dopamine. Whether this increased differen-
tiation potential is an indication of additional selection during the expansion period or whether exposure of the 
cells to an extended period of mFPP induction was the major benefit remains to be established. However, the 
expanded mFPPs retained the ability to differentiate into DA neurons in animal models and did not show signs 
of transformation. Thus, taking advantage of the endogenous signaling pathways that mediate mesencephalic DA 
neuron differentiation, the resulting human mFPPs retain the ability to respond to endogenous cues in the mid-
brain tissue of host mouse embryos and to generate neurons that integrate in the host substantia nigra and project 
to the striatum, their correct target region in the brain. Future analysis will be required to assess their integration 
into the nigro-striatal circuitry and to be able to functionally rescue animal modes of DA neuron degeneration. 
However, based on our analyses and the similarities between the DA neurons generated by expanded mFPPs and 
the standard direct mFPP-derived DA neurons described previously, they most likely will also have the potential 
to rescue symptoms in disease models11, 28.
In summary, we describe and validate a protocol for the long-term expansion and propagation of mFPPs that 
circumvents some of the challenges faced with other, none mFPP procedures, and that provides a robust means 
to bank highly homogeneous cultures of DA progenitors for gene function analysis and potential drug screening. 
This procedure may provide a convenient and scalable source of cells for eventual cell replacement therapy.
Methods
Animals and husbandry. C57/BL6 mice were kept on a 12-hour day/night cycle with food and water ad 
libitum under specified pathogen free conditions in accordance with Swiss federal and Swiss veterinary office 
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regulations. All experimental protocols were approved by the ethics commission of BaselStadt, Basel, Switzerland. 
All experimental procedures were carried out in accordance with Swiss Federal and Swiss veterinary office regu-
lations under license numbers 2537 and 2538.
Human iPSC culture and DA neuron differentiation. Human induced pluripotent stem cell (hiPSCs) 
lines NAS2, Invitrogen hiPSC and F3 (Dr. Ginetta Collo, manuscript submitted), were maintained on Matrigel in 
mTeSR-1 medium and passaged enzymatically with Accutase every 4–5 days (see online methods for details). DA 
neuron differentiation was induced using modifications to the FPP method11. Detailed description of the protocol 
can be found on the online version of the Methods.
RNA isolation and RT-PCR/qPCR analysis. For RNA isolation, cells were lysed directly in Trizol 
(Invitrogen) reagent. RNA was isolated according to the manufacturer’s instructions. 1 μg of total RNA was used 
for cDNA synthesis using oligo (dT) primers and Superscript III first strand kit (Invitrogen). For RT-PCR anal-
ysis, cDNA was amplified using 5x FIREPol Master Mix (Solis BioDyne, #04-11-00125). For RT-qPCR analysis, 
cDNA amplification was performed using SensiFast Sybr HiROX kit (Bioline, #Bio-92020). Primer information 
was provided in the Supplementary Table S2.
Fluorescence activated cell sorting for neuronal quantification. The protocol was adapted from 
Turac et al.50. After differentiation, cells were detached enzymatically with Accutase and a gentle resuspension 
was applied in order to obtain single cells. Primary antibodies used for flow cytometric analysis are shown 
in Supplementary Table S1. After primary antibody incubation, the cells were washed in PBS, centrifuged at 
5000 rpm for 3 minutes and then resuspended in PBS and incubated with the appropriate secondary antibodies 
(Jackson Immunoresearch) for 30 minutes at room temperature on a shaker in the dark. Finally, cells were washed 
in PBS and centrifuged at least 3 times, resuspend in 2% FBS in PBS and filtered through a 40 μm cell sieve 
(Miltenyi Biotec). The cells were sorted on a fluorescence-activated cell sorter FACS Canto II (BD Biosciences) 
and analyzed using FACSDiva software (BD Biosciences). Data were additionally analyzed and presented using 
FlowJo software.
Quantification and statistical analysis. Stained coverslips or sections were analyzed with fixed photo-
multiplier settings on a Zeiss Observer with Apotome (Zeiss) or Zeiss LSM510 confocal microscope (Zeiss). Data 
are presented as averages of a minimum of three independent differentiation experiments. Statistical comparisons 
were determined by two-tailed unpaired Student’s t-test, Kruskal-Wallis with Dunn post-hoc test and two way 
ANOVA test for cross comparison of 3 and more data sets. Significance was established at *p < 0.05. In all graphs, 
deviance from mean was displayed as standard error of the mean, SEM.
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